As of 2025-02-13, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 5.68 USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.82 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is -72.7%.
The range of the Relative Valuation is 3.39 - 8.55 USD.
Range | Selected | |
Trailing P/E multiples | 16.5x - 38.8x | 27.6x |
Forward P/E multiples | 15.4x - 32.4x | 23.9x |
Fair Price | 3.39 - 8.55 | 5.68 |
Upside | -83.7% - -59.0% | -72.7% |
Date | P/E |
2025-02-07 | 99.61 |
2025-02-06 | 110.73 |
2025-02-05 | 103.70 |
2025-02-04 | 94.71 |
2025-02-03 | 96.07 |
2025-01-31 | 98.29 |
2025-01-30 | 102.61 |
2025-01-29 | 102.11 |
2025-01-28 | 100.61 |
2025-01-27 | 98.61 |
2025-01-24 | 100.65 |
2025-01-23 | 100.52 |
2025-01-22 | 99.02 |
2025-01-21 | 99.02 |
2025-01-17 | 91.39 |
2025-01-16 | 78.77 |
2025-01-15 | 81.77 |
2025-01-14 | 75.77 |
2025-01-13 | 77.68 |
2025-01-10 | 73.78 |
2025-01-08 | 73.78 |
2025-01-07 | 77.59 |
2025-01-06 | 75.37 |
2025-01-03 | 78.91 |
2025-01-02 | 78.63 |
2024-12-31 | 76.36 |
2024-12-30 | 74.77 |
2024-12-27 | 74.91 |
2024-12-26 | 78.36 |
2024-12-24 | 74.64 |
2024-12-23 | 77.86 |
2024-12-20 | 77.59 |
2024-12-19 | 78.13 |
2024-12-18 | 77.50 |
2024-12-17 | 83.76 |
2024-12-16 | 86.90 |
2024-12-13 | 85.85 |
2024-12-12 | 86.31 |
2024-12-11 | 88.67 |
2024-12-10 | 93.34 |
2024-12-09 | 105.15 |
2024-12-06 | 115.54 |
2024-12-05 | 118.18 |
2024-12-04 | 120.27 |
2024-12-03 | 122.81 |
2024-12-02 | 122.81 |
2024-11-29 | 125.35 |
2024-11-27 | 126.58 |
2024-11-26 | 121.22 |
2024-11-25 | 118.45 |